Cipher Pharmaceuticals ($CPH.TO) FINS Review

Q3 2024

So many requests for this one over the past few months. It’s been a long time since their Q3 was released and normally I shy away from reviewing financials this old, but it’s also one that I’ve wanted to take a look at for some time, so why not?

Longs have to be ecstatic as you could have had this in the $5.50 range at the beginning of the year and currently sits 165% above that. It is also off by about five bucks from it’s 52 week high back in August. What do the financials tell us?